ANI Pharmaceuticals, Inc.
ANIP
$61.46
-$1.81-2.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -198.63% | -152.99% | 623.65% | 235.02% | 139.21% |
| Total Depreciation and Amortization | 13.28% | 0.26% | -0.88% | -0.03% | 0.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.38% | -24.67% | -71.08% | -77.25% | 86.20% |
| Change in Net Operating Assets | -144.99% | 203.88% | 148.23% | 138.89% | 148.46% |
| Cash from Operations | -46.19% | 33.05% | 172.80% | 1,163.82% | 481.24% |
| Capital Expenditure | -83.09% | -65.73% | -24.79% | -19.66% | 0.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 1,701.87% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.56% | 56.19% | 54.50% | -31.07% | -27.23% |
| Cash from Investing | -2,086.37% | -2,263.50% | 78.10% | 54.60% | -17.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9,767.70% | -9,787.50% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -92.75% | -92.35% | -86.61% | 5,606.27% | 6,042.04% |
| Repurchase of Common Stock | -119.75% | -123.02% | -144.42% | -130.05% | -154.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.06% | 0.06% | 0.06% | 0.00% |
| Other Financing Activities | -493.42% | -- | -- | -- | -- |
| Cash from Financing | 292.87% | 227.12% | -139.55% | 805.85% | 1,415.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.40% | -136.47% | -15.99% | 1,236.36% | 422.44% |
